SHMT2 and cancer: Acetylation of SHMT2 at K95 disrupts its structure and function, leading to lysosomal degradation, reduced serine metabolism, and suppressed proliferation; autophagy contributes by degrading acetylated SHMT2 to limit cancer growth [65].